Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
|
|
|
33.
|
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. [electronic resource] by
- Elkon, K B
- Liu, C C
- Gall, J G
- Trevejo, J
- Marino, M W
- Abrahamsen, K A
- Song, X
- Zhou, J L
- Old, L J
- Crystal, R G
- Falck-Pedersen, E
Producer: 19971001
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 94
Availability: No items available.
|
|
|
34.
|
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. [electronic resource] by
- Kaner, R J
- Worgall, S
- Leopold, P L
- Stolze, E
- Milano, E
- Hidaka, C
- Ramalingam, R
- Hackett, N R
- Singh, R
- Bergelson, J
- Finberg, R
- Falck-Pedersen, E
- Crystal, R G
Producer: 19990402
In:
American journal of respiratory cell and molecular biology vol. 20
Availability: No items available.
|
|
|
35.
|
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. [electronic resource] by
- Mack, C A
- Song, W R
- Carpenter, H
- Wickham, T J
- Kovesdi, I
- Harvey, B G
- Magovern, C J
- Isom, O W
- Rosengart, T
- Falck-Pedersen, E
- Hackett, N R
- Crystal, R G
- Mastrangeli, A
Producer: 19970326
In:
Human gene therapy vol. 8
Availability: No items available.
|